These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease]. Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385 [TBL] [Abstract][Full Text] [Related]
4. [The role of a pediatric endocrinologist in diagnostics and therapeutic management of anorexia nervosa--own experiences and review of literature]. Roztoczyńska D; Starzyk J Przegl Lek; 2009; 66(1-2):52-7. PubMed ID: 19485257 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of Raynaud's phenomenon]. Guilmot JL; Diot E; Lasfargues G Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1755-60. PubMed ID: 1685081 [TBL] [Abstract][Full Text] [Related]
6. Osteopenia and osteoporosis in anorexia nervosa. Golden NH Adolesc Med; 2003 Feb; 14(1):97-108. PubMed ID: 12529194 [TBL] [Abstract][Full Text] [Related]
7. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases]. Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558 [TBL] [Abstract][Full Text] [Related]
8. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. Rychlik-Golema W; Mastej K; Adamiec R Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Raynaud's phenomenon. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160 [TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon: pathogenesis and management. Bakst R; Merola JF; Franks AG; Sanchez M J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists]. Shcherbakov AB Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706 [TBL] [Abstract][Full Text] [Related]
17. Raynaud's phenomenon in mixed connective tissue disease. Grader-Beck T; Wigley FM Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319 [TBL] [Abstract][Full Text] [Related]
18. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
19. Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study. Wu YJ; Luo SF; Yang SH; Chen JY; Yu KH; See LC Chang Gung Med J; 2008; 31(5):492-502. PubMed ID: 19097597 [TBL] [Abstract][Full Text] [Related]
20. [The determination of the thermal threshold in subjects with Raynaud's disease. A preliminary report of 2 clinical cases]. Luca S; Romeo S Minerva Cardioangiol; 1999 Jun; 47(6):213-7. PubMed ID: 10522147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]